Agran Libbie’s GSK GSK Stock Holding History

Agran Libbie’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,520	Closed	-$203K	–	125
2015 Q1	$203K	Buy	+3,520	New	+$202K	0.05%	133
2014 Q4	–	Sell	-3,520	Closed	-$202K	–	130
2014 Q3	$202K	Hold	3,520	–	–	0.05%	123
2014 Q2	$235K	Hold	3,520	–	–	0.06%	108
2014 Q1	$235K	Hold	3,520	–	–	0.06%	106
2013 Q4	$235K	Hold	3,520	–	–	0.06%	110
2013 Q3	$221K	Hold	3,520	–	–	0.06%	101
2013 Q2	$220K	Buy	+3,520	New	+$223K	0.06%	108

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Agran Libbie's GSK Position: Q2 2015 in Review

Agran Libbie sold out of GSK (GSK) in Q2 2015, closing a stake of 3,520 shares — an estimated $203K sold.

Agran Libbie first reported a position in GSK in Q2 2013 and held it in 7 quarters. The position peaked at $235K in Q2 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Agran Libbie reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
Agran Libbie sold 3,520 GSK shares in Q2 2015, an estimated $203K.
Agran Libbie first reported a position in GSK in Q2 2013 and held it in 7 quarters.
Agran Libbie's GSK position peaked at $235K in Q2 2014.
719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Agran Libbie's 13F filing for Q2 2015, filed 28 Jul 2015.